Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study

BACKGROUND: Management guidelines for chronic obstructive pulmonary disease (COPD) recommend that inhaled corticosteroids (ICS) are prescribed to patients with the most severe symptoms. However, these guidelines have not been widely implemented by physicians, leading to widespread use of ICS in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, David B., Russell, Richard, Mares, Rafael, Burden, Anne, Skinner, Derek, Mikkelsen, Helga, Ding, Cherlyn, Brice, Richard, Chavannes, Niels H., Kocks, Janwillem W. H., Stephens, Jeffrey W., Haughney, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033451/
https://www.ncbi.nlm.nih.gov/pubmed/27658209
http://dx.doi.org/10.1371/journal.pone.0162903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033451/
https://www.ncbi.nlm.nih.gov/pubmed/27658209
http://dx.doi.org/10.1371/journal.pone.0162903

Ejemplares similares